Back

COVID-19 vaccine associated myocarditis in Norway - a nationwide validation study

31 August 2024 (12:00 - 12:40)
Organised by: Logo
Congress Presentation Part of: Myocarditis: good tools for predicting bad outcomes Epidemiology, Prognosis, Outcome ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Bendik Skinningsrud Hagen

Oslo University Hospital Rikshospitalet, Oslo (Norway)

6 More presentations in this session

Presentation thumbnail
Novel risk scoring model to assess the need for venoarterial-extracorporeal membrane oxygenation in patients with acute myocarditis
Doctor D. Hong (Seoul, KR)
Abstract Slides Video
Presentation thumbnail
Baseline C-reactive protein as a predictor of non-ischemic LGE in myocarditis
Doctor M. Bernardi (Rome, IT)
Abstract Slides Video
Presentation thumbnail
Myocarditis in the modern era: analysing the impact of high-sensitivity troponin & C-reactive protein in predicting the extent of myocarditis and LV systolic dysfunction on cardiac magnetic resonance
Doctor Z. Hussein (Coventry, GB)
Abstract Slides Video
Presentation thumbnail
Comparative evaluation of approach sites in right ventricular biopsy: influence on complication rates, particularly conduction defects.
Doctor S. Yoshida (Kanazawa, JP)
Abstract Slides Video
Presentation thumbnail
Prognostic value of baseline and follow-up ECG in patients with biopsy-proven fulminant myocarditis
Doctor M. Ciabatti (Arezzo, IT)
Abstract Slides Video

Access the full session

Session thumbnail
Myocarditis: good tools for predicting bad outcomes

The Event

Event poster

ESC Congress 2024

31 August 2024 12:00 CET
You may be interested in
thumbnail
Congress Presentation
Normal cardiac function but discrete late gadolinium enhancement findings after COVID-19 vaccine-associated myocarditis - a nationwide long-term follow-up study
thumbnail
Congress Presentation
Long term cardiac function and symptoms in patients following COVID-19 vaccination myocarditis
thumbnail
Congress Presentation
Safety of COVID-19 vaccines regarding cardiovascular events: a systematic review and meta-analysis

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources